Advisory Board January 22, 2024
GLP-1s, a class of weight loss and diabetes drugs, has taken the healthcare industry by storm, with J.P. Morgan Research projecting the GLP-1 market to surpass $100 billion in revenue by 2030, Gabriel Perna reports for Modern Healthcare. Advisory Board’s Rachael Peroutky explains why the telehealth market for these drugs is worth watching.
The organizations selling GLP-1s on the telehealth market
1. Mayo Clinic
On Wednesday, the Mayo Clinic announced it will test a telehealth weight loss offering through its diet program. The Clinic will provide GLP-1s as well as video consultations alongside Amwell Medical Group physicians.
2. Transcarent
Transcarent on Wednesday announced it will work alongside 9amHealth to add a weight loss program for employers who are self-insured.
This...
Today's Sponsors
Today's Sponsor